Vascular smooth muscle contraction pathway proteins (null)

Vascular smooth muscle contraction pathway proteins comprise a network of ion channels, receptors, kinases, and contractile apparatus proteins that regulate the contraction and relaxation of vascular smooth muscle cells. Key components include L-type calcium channels (CaV1.2), various potassium channels (KV1.x, KV7.x), TRP channels (e.g., TRPV4), myosin light-chain kinase (MLCK), myosin phosphatase, and G protein-coupled receptors (such as the angiotensin II receptor, alpha-adrenergic receptor, and S1P2 receptor)[1][3][4][5][8][9]. These proteins mediate intracellular signaling cascades, calcium influx, and phosphorylation events that control actin–myosin interaction, thereby modulating vessel diameter and systemic blood pressure. Pharmacological modulation of this pathway underlies the action of many antihypertensive drug classes and is being explored for cardiovascular therapeutics, but targeting the pathway can be challenging due to complex feedback mechanisms and potential safety concerns.

Other names

VSMC contraction pathway proteinssmooth muscle contraction pathway proteins

Inhibition of calcium influx (reducing contraction; e.g., calcium channel blockers) Blockade of GPCR signaling (e.g., ARBs, alpha-blockers) Inhibition of Rho/ROCK pathway (vasodilation) Inhibition of PKC (reduces phosphorylation events driving contraction)